Skip to main content

3 Result(s)

within D. Neofytos Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

    Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albic...

    A. T. Coste, A. Kritikos, J. Li, N. Khanna, D. Goldenberger, C. Garzoni… in Infection (2020)

    Download PDF (768 KB) View Article

  2. No Access

    Article

    Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry

    Candida osteomyelitis is associated with significant morbidity; however, data on the management of Candida osteomyelitis are limited. The Prospective Antifungal Therapy (PATH) Alliance® registry ...

    D. Neofytos, S. Huprikar, A. Reboli… in European Journal of Clinical Microbiology … (2014)

  3. No Access

    Article

    Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia

    Candidemia is an increasing complication of the care of complex patients. Adherence to Infectious Diseases Society of America (IDSA) guidelines for the treatment of candidemia was investigated to assess the im...

    D. Horn, D. Neofytos, J. Fishman… in European Journal of Clinical Microbiology … (2007)